These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24081958)

  • 21. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy and its role in the management of heart failure.
    McAloon CJ; Theodoreson MD; Hayat S; Osman F
    Br J Hosp Med (Lond); 2017 Jun; 78(6):312-319. PubMed ID: 28614025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter by Filgueiras-Rama et al regarding article, "Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy" by Miranda et al.
    Filgueiras-Rama D; Garofalo D; Gómez-Gallanti A
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):e24. PubMed ID: 23592876
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R
    Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 20 years of cardiac resynchronization therapy.
    Leyva F; Nisam S; Auricchio A
    J Am Coll Cardiol; 2014 Sep; 64(10):1047-58. PubMed ID: 25190241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy: from treatment to prevention.
    Leclercq C; Singh JP
    Eur Heart J; 2011 Jul; 32(13):1580-2. PubMed ID: 21324935
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
    Choi AJ; Thomas SS; Singh JP
    Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply: To PMID 25465934.
    Sassone B; Bertini M
    Am J Cardiol; 2015 Jun; 115(12):1781-2. PubMed ID: 25910526
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.
    D'Onofrio A; Botto G; Mantica M; LA Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Bianchi V; Gelmini GP; Valsecchi S; Ciardiello C
    J Cardiovasc Electrophysiol; 2014 May; 25(5):500-506. PubMed ID: 24494797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of long-term outcomes between narrow and broad QRS complex patients treated with cardiac resynchronization therapy.
    Yap LB; Nguyen ST; Qadir F; Ma SK; Muhammad Z; Koh KW; Ali Z; Tay GS; Daud A; Said A; Sahat N; Rebo R; Tamin SS; Hussin A; Kaur S; Omar R
    Acta Cardiol; 2016 Jun; 71(3):323-30. PubMed ID: 27594128
    [No Abstract]   [Full Text] [Related]  

  • 36. Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.
    Verbrugge FH; Dupont M; Rivero-Ayerza M; de Vusser P; Van Herendael H; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
    J Card Fail; 2012 Nov; 18(11):845-53. PubMed ID: 23141857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of left ventricular reverse remodeling.
    Aksu U; Kalkan K
    Int J Cardiol; 2016 Nov; 222():1055. PubMed ID: 27138699
    [No Abstract]   [Full Text] [Related]  

  • 38. Troubleshooting Cardiac Resynchronization Therapy in Nonresponders.
    Dhesi S; Lockwood E; Sandhu RK
    Can J Cardiol; 2017 Aug; 33(8):1060-1065. PubMed ID: 28666618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The QRS narrowing index for easy and early identification of responder to cardiac resynchronization therapy.
    Coppola G; Bonaccorso P; Corrado E; Ciaramitaro G; Ajello L; Nugara C; Assennato P
    Int J Cardiol; 2014 Jan; 170(3):440-1. PubMed ID: 24342404
    [No Abstract]   [Full Text] [Related]  

  • 40. Does cardiac resynchronization therapy benefit patients with right bundle branch block: cardiac resynchronization therapy has a role in patients with right bundle branch block.
    Auricchio A; Lumens J; Prinzen FW
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):532-42. PubMed ID: 24951571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.